PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-16

Date Title Company
16-Oct-2025 LegitScript Reports Record Growth and Expanding Global Impact in Digital Health Certification Businesswire
16-Oct-2025 New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub Businesswire
16-Oct-2025 Ulta Beauty Names Christopher DelOrefice as Chief Financial Officer Businesswire
16-Oct-2025 ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program Businesswire
16-Oct-2025 Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance Businesswire
16-Oct-2025 Vistagen to Present at The Menopause Society 2025 Annual Meeting Businesswire
16-Oct-2025 Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform Businesswire
16-Oct-2025 Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis Businesswire
16-Oct-2025 bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer Businesswire
16-Oct-2025 OmniAb to Participate in Three Investor Conferences in November Businesswire
16-Oct-2025 Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI Businesswire
16-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
16-Oct-2025 Doron Therapeutics Announces First Patients Dosed in Phase 3 Study of MOTYS (PTP-001) for the Treatment of Osteoarthritis of the Knee Businesswire
16-Oct-2025 Odyssey Behavioral Healthcare 2024 Outcomes Report Shows Record Symptom Reductions Across Psychiatric, Eating Disorder Networks ACCESS Newswire
16-Oct-2025 Helen's Pink Sky Foundation to Feature on BWT Alpine Formula One Team's A525 to Raise Awareness of Batten Disease during the Formula 1 United States Grand Prix 2025 ACCESS Newswire
16-Oct-2025 Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA) Businesswire
16-Oct-2025 Brook.ai Secures $28 Million in Series B Funding, Led by UMass Memorial Health and Morningside, to Accelerate Next Phase of Growth and Innovation in Remote Care Brook.ai
16-Oct-2025 Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIRâ„¢ EVERSANA
16-Oct-2025 Orbia Fluor & Energy Materials delivers first ISO tank of low-GWP propellant Orbia Flour & Energy Materials
16-Oct-2025 Consumer Healthcare Products Association Joins the International Collaboration on Cosmetics Safety Businesswire